Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Intercept Pharmaceuticals...

    NASDAQ: ICPT · Real-Time Price · USD
    19.00
    0.04 (0.21%)
    At close: Nov 07, 2023, 10:00 PM

    Intercept Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 285.71M 363.47M
    Cost of Revenue
    		 984K 3.1M
    Gross Profit
    		 284.73M 360.37M
    Operating Income
    		 -68.22M -55.76M
    Interest Income
    		 15.51M 47.77M
    Pretax Income
    		 -174.86M -91.43M
    Net Income
    		 115.17M -145.02M
    Selling & General & Admin
    		 176.3M 230.85M
    Research & Development
    		 176.64M 185.27M
    Other Expenses
    		 n/a 2.15M
    Operating Expenses
    		 352.94M 416.13M
    Interest Expense
    		 21.39M 54.42M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 353.93M 419.23M
    Income Tax Expense
    		 -290.03M 53.6M
    Shares Outstanding (Basic)
    		 33.82M 31.86M
    Shares Outstanding (Diluted)
    		 33.84M 31.89M
    EPS (Basic)
    		 3.41 -4.55
    EPS (Diluted)
    		 3.40 -4.55
    EBITDA
    		 -61.7M -53.6M
    EBIT
    		 -153.47M -37.01M
    Depreciation & Amortization
    		 6.52M 2.15M

    Add to Watchlist